Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial
T Kempf, A Guba-Quint, J Torgerson… - European Journal of …, 2012 - academic.oup.com
Objective Growth differentiation factor-15 (GDF-15) is a stress-responsive cytokine that is
increased in obesity and established type 2 diabetes. We assessed whether GDF-15 can …
increased in obesity and established type 2 diabetes. We assessed whether GDF-15 can …
Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial
T Kempf, A Guba-Quint, J Torgerson… - European journal …, 2012 - pubmed.ncbi.nlm.nih.gov
Objective Growth differentiation factor-15 (GDF-15) is a stress-responsive cytokine that is
increased in obesity and established type 2 diabetes. We assessed whether GDF-15 can …
increased in obesity and established type 2 diabetes. We assessed whether GDF-15 can …
Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial.
T Kempf, A Guba-Quint, J Torgerson… - European Journal …, 2012 - search.ebscohost.com
Abstract Objective: Growth differentiation factor-15 (GDF-15) is a stress-responsive cytokine
that is increased in obesity and established type 2 diabetes. We assessed whether GDF-15 …
that is increased in obesity and established type 2 diabetes. We assessed whether GDF-15 …
Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial
T Kempf, A Guba-Quint, J Torgerson… - European Journal of …, 2012 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objective</jats: title>< jats: p> Growth differentiation factor-15
(GDF-15) is a stress-responsive cytokine that is increased in obesity and established type 2 …
(GDF-15) is a stress-responsive cytokine that is increased in obesity and established type 2 …
Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial.
T Kempf, A Guba-Quint, J Torgerson, MC Magnone… - 2012 - cabidigitallibrary.org
Abstract Objective: Growth differentiation factor-15 (GDF-15) is a stress-responsive cytokine
that is increased in obesity and established type 2 diabetes. We assessed whether GDF-15 …
that is increased in obesity and established type 2 diabetes. We assessed whether GDF-15 …
Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial.
T Kempf, A Guba-Quint, J Torgerson… - European Journal of …, 2012 - europepmc.org
Objective Growth differentiation factor-15 (GDF-15) is a stress-responsive cytokine that is
increased in obesity and established type 2 diabetes. We assessed whether GDF-15 can …
increased in obesity and established type 2 diabetes. We assessed whether GDF-15 can …
[引用][C] Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial
T KEMPF, A GUBA-QUINT… - European journal of …, 2012 - pascal-francis.inist.fr
Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in
obese nondiabetic individuals: results from the XENDOS trial CNRS Inist Pascal-Francis CNRS …
obese nondiabetic individuals: results from the XENDOS trial CNRS Inist Pascal-Francis CNRS …